CTOs on the Move

Modulim

www.modulim.com

 
Modulim is a pioneer in optical imaging solutions powered by spatial frequency domain imaging (SFDI) for noninvasive tissue and vascular assessment. Powered by SFDI, our Clarifi® Imaging System helps clinicians identify patients at-risk of complications due to microvascular dysfunction. The #ClarifiImagingSystem quantifies and maps five biomarkers of microvascular tissue oxygenation and perfusion. As a result, clinicians can quickly identify at-risk patients for earlier and more timely intervention so they may prevent complications such as diabetic foot ulcers and amputations. With its widespread adoption, our technology solutions have the potential to save limbs and lives, improve outcomes and reduce costs across the continuum ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.modulim.com
  • 2400 Barranca Parkway Suite 2B
    Irvine, CA USA 92606
  • Phone: 949.825.5080

Executives

Name Title Contact Details

Similar Companies

Episode Solutions

Episode Solutions provides resources and services, tailored exclusively to the needs of musculoskeletal physicians and physicians groups, to help evaluate and maximize physician performance in alternative payment structures, without sacrificing existing professional fee-for-service revenue. Episode Solutions provides the platform that enables MSK physicians to take advantage of the substantial opportunities to create and share in immediate savings through bundled payments.

MediChair/Medi-E-Ox

MediChair/Medi-E-Ox is a Goderich, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Exo

Exo (pronounced “Echo”) is pioneering a high-performance handheld ultrasound platform and AI for imaging and therapeutic applications.

Next Step Orthotics

Next Step Orthotics is a Manchester, NH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Apollo Endosurgery

Apollo Endosurgery, Inc. is a medical device company focused on less invasive therapies for the treatment of obesity, a condition facing over 600 million people globally, as well as other gastrointestinal conditions. Apollo`s device based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo`s products are offered in over 70 countries today and include the OverStitch™ Endoscopic Suturing System, the X-Tack™ Endoscopic HeliX Tacking System, and the ORBERA® Intragastric Balloon.